Triaziquone
Clinical data | |
---|---|
ATC code | L01AC02 (WHO) |
Identifiers | |
| |
Synonyms | 2,3,5-Tris(aziridin-1-yl)cyclohexa-2,5-diene-1,4-dione |
CAS Number | 68-76-8 |
PubChem (CID) | 6235 |
ChemSpider | 5999 |
UNII | F3D5D9P25I |
KEGG | C19542 |
ChEBI | CHEBI:27090 |
ECHA InfoCard | 100.000.629 |
Chemical and physical data | |
Formula | C12H13N3O2 |
Molar mass | 231.25 g/mol |
3D model (Jmol) | Interactive image |
| |
| |
(what is this?) (verify) |
Triaziquone is a drug used in chemotherapy.
It is an alkylating agent.[1] It can react with DNA to form intrastrand crosslinks.
References
- ↑ Begleiter A (2000). "Clinical applications of quinone-containing alkylating agents". Front. Biosci. 5: E153–71. doi:10.2741/A483. PMID 11056078.
This article is issued from Wikipedia - version of the 4/2/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.